Rebel Medicine
PrivateLast Round
Series A
Jun 4, 2026
Total Funding Raised
$11.16M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Rebel Medicine is a biotechnology company that develops non-opioid pharmaceutical products for acute and post-operative pain management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebel Medicine Comparables
Compare Rebel Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concentric Analgesic | 88% | |
| Allay Therapeutics | 84% | |
| Virpax Pharmaceuticals Inc | 84% |
Rebel Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 4, 2026 | ||||
| Series A | Jun 12, 2025 | ||||
| Seed | Feb 6, 2025 | ||||
| Grant | Sep 1, 2020 |
Rebel Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Utah Innovation Fund | Series A |
| Central Texas Angel Network | Series A, Seed |
| S.K. Hart Management | Series A |
| Crocker Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 116% MoM, reaching 3.8K.
- Jul 26, 2026
Monthly visitors grew 45% MoM, reaching 1.8K.
Rebel Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rebel Medicine's valuation, stock price, and market status.
Is Rebel Medicine a public or private company?
Rebel Medicine is a private company.
What is the current stock price of Rebel Medicine?
Rebel Medicine is a private company, so its shares have no public market price. Caplight tracks Rebel Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rebel Medicine worth (valuation)?
Valuation information for Rebel Medicine is not publicly available.
Can I buy Rebel Medicine stock?
Rebel Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rebel Medicine's last funding round?
Rebel Medicine's most recent funding round was Series A on June 4, 2026.
Who are the main investors in Rebel Medicine?
Key investors in Rebel Medicine include Central Texas Angel Network, Crocker Ventures.
Will Rebel Medicine IPO soon?
No public IPO plans have been announced for Rebel Medicine.
How can I track Rebel Medicine secondary market activity?
Caplight tracks bids, offers, and trades in Rebel Medicine's shares on secondary markets.